DEUTSCHE BANK AG\ - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 114 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$275,000
-57.3%
45,651
-74.5%
0.00%
Q3 2019$644,000
+2.9%
179,274
-23.5%
0.00%
Q2 2019$626,000
-57.6%
234,449
-53.1%
0.00%
-100.0%
Q1 2019$1,477,000
+249.2%
499,420
+87.1%
0.00%
Q4 2018$423,000
-92.1%
266,931
-81.7%
0.00%
-100.0%
Q3 2018$5,362,000
-52.4%
1,457,770
-63.4%
0.00%
-33.3%
Q2 2018$11,259,000
+61.0%
3,978,914
+111.1%
0.00%0.0%
Q1 2018$6,992,000
-5.4%
1,885,235
-26.5%
0.00%
-40.0%
Q4 2017$7,388,000
-1.2%
2,566,018
+54.1%
0.01%0.0%
Q3 2017$7,474,000
+24.7%
1,665,159
+27.5%
0.01%
+25.0%
Q2 2017$5,992,000
-1.9%
1,305,900
-10.0%
0.00%
-20.0%
Q1 2017$6,109,000
-17.4%
1,451,693
-19.0%
0.01%
-16.7%
Q4 2016$7,396,000
-48.3%
1,791,322
+1.5%
0.01%
-40.0%
Q3 2016$14,297,000
+23.2%
1,765,275
+18.7%
0.01%
+25.0%
Q2 2016$11,600,000
+10.0%
1,487,623
+8.8%
0.01%0.0%
Q1 2016$10,550,000
-31.0%
1,366,854
-3.6%
0.01%
-27.3%
Q4 2015$15,288,000
+212.8%
1,417,274
+100.3%
0.01%
+175.0%
Q3 2015$4,887,000
-10.1%
707,551
+15.2%
0.00%
+33.3%
Q2 2015$5,438,000
-39.0%
614,168
-32.1%
0.00%
-50.0%
Q1 2015$8,910,000
+70.0%
903,974
+111.1%
0.01%
+100.0%
Q4 2014$5,242,000
+51.2%
428,169
+23.1%
0.00%
+50.0%
Q3 2014$3,467,000
+99.7%
347,685
+51.5%
0.00%
+100.0%
Q2 2014$1,736,000
+1.7%
229,568
-55.8%
0.00%0.0%
Q1 2014$1,707,000
+62.7%
519,152
+62.0%
0.00%0.0%
Q4 2013$1,049,000
+44.7%
320,515
+31.1%
0.00%0.0%
Q3 2013$725,000244,4280.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders